Login / Signup

Efficacy and safety of deferoxamine, deferasirox and deferiprone triple iron chelator combination therapy for transfusion-dependent β-thalassaemia with very high iron overload: a protocol for randomised controlled clinical trial.

Anuja PremawardhenaChamodi PereraMuditha Nayana WijethilakaSakuni Keshani WanasingheR H M G RajakarunaR A N K K SamarasingheSenani WilliamsSachith Mettananda
Published in: BMJ open (2024)
The trial is registered in the Sri Lanka Clinical Trials Registry (Ref: SLCTR/2023/010).
Keyphrases
  • clinical trial
  • study protocol
  • phase ii
  • phase iii
  • randomized controlled trial
  • iron deficiency
  • open label
  • double blind
  • cardiac surgery
  • sickle cell disease
  • acute kidney injury